Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001731122-25-001025
Filing Date
2025-07-25
Accepted
2025-07-25 16:48:24
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 e6731_424b5.htm 424B5 502524
2 GRAPHIC image_001.gif GRAPHIC 2755
3 GRAPHIC image_002.gif GRAPHIC 2785
4 GRAPHIC image_003.gif GRAPHIC 2822
  Complete submission text file 0001731122-25-001025.txt   515572
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-288661 | Film No.: 251152192
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)